Ultragenyx Pharmaceutical Inc. (RARE) SEC Filings — 2024
27 SEC filings for Ultragenyx Pharmaceutical Inc. (RARE) in 2024.
Filings
- Ultragenyx Pharmaceutical Inc. Files 8-K — 8-K · Dec 19, 2024
- Ultragenyx Pharmaceutical Inc. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- Ultragenyx Sells Woburn Facility to Catalent for $100M — 8-K · Nov 12, 2024
- Ultragenyx Pharmaceutical Inc. Files Q3 2024 10-Q Report — 10-Q · Nov 6, 2024
- Ultragenyx Pharmaceutical Inc. Files 8-K — 8-K · Nov 5, 2024
- Ultragenyx Pharmaceutical Inc. Files 8-K — 8-K · Oct 7, 2024
- Ultragenyx Pharmaceutical Inc. Files 8-K — 8-K · Oct 3, 2024
- Ultragenyx Pharmaceutical Inc. Files Q2 2024 10-Q — 10-Q · Aug 2, 2024
- Ultragenyx Pharmaceutical Files 8-K on Financials — 8-K · Aug 1, 2024
- Ultragenyx Sells European Crysvita Rights to Novo Nordisk for $300M — 8-K · Jul 17, 2024
- Ultragenyx Pharmaceutical Inc. Files 8-K with Officer, Director, and Compensation Updates — 8-K · Jun 21, 2024
- Ultragenyx Pharmaceutical Inc. Files 8-K — 8-K · Jun 17, 2024
- Ultragenyx Sells European Ops for $100M — 8-K · Jun 12, 2024
- Ultragenyx Pharmaceutical Inc. Files 8-K — 8-K · May 30, 2024
- Ultragenyx Pharmaceutical Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 3, 2024
- Ultragenyx Pharmaceutical Inc. Files 8-K — 8-K · May 2, 2024
- Ultragenyx Pharmaceutical Inc. Files Definitive Proxy Statement — DEF 14A · Apr 26, 2024
- Ultragenyx Pharmaceutical Inc. Files 8-K — 8-K · Apr 15, 2024
- Ultragenyx Pharmaceutical Inc. Files 2023 Annual Report — 10-K · Feb 21, 2024
- Ultragenyx Files 8-K on Financial Results & Operations — 8-K · Feb 15, 2024
- Ultragenyx Pharmaceutical Inc. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- Ultragenyx Pharmaceutical Inc. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- Ultragenyx Pharmaceutical Inc. SC 13G/A Filing — SC 13G/A · Feb 13, 2024
- Ultragenyx Pharmaceutical Inc. SC 13G Filing — SC 13G · Feb 13, 2024
- Wellington Management Amends Ultragenyx Stake, Maintains Position — SC 13G/A · Feb 8, 2024
- BlackRock Amends Ultragenyx Stake, Maintains Significant Position — SC 13G/A · Jan 29, 2024
- Ultragenyx Files 8-K on Jan 7, Signals Upcoming Disclosure — 8-K · Jan 8, 2024